| Guidelines for inclusion of patient-reported outcomes in clinical trial protocols: the SPIRIT-PRO extension M Calvert, D Kyte, R Mercieca-Bebber, A Slade, AW Chan, MT King, ... Jama 319 (5), 483-494, 2018 | 661 | 2018 |
| The importance of patient-reported outcomes in clinical trials and strategies for future optimization R Mercieca-Bebber, MT King, MJ Calvert, MR Stockler, M Friedlander Patient related outcome measures, 353-367, 2018 | 419 | 2018 |
| Survivorship care plans in cancer: a meta‐analysis and systematic review of care plan outcomes RE Hill, CE Wakefield, RJ Cohn, JE Fardell, MEE Brierley, E Kothe, ... The Oncologist 25 (2), e351-e372, 2020 | 131 | 2020 |
| Mode of administration does not cause bias in patient-reported outcome results: a meta-analysis C Rutherford, D Costa, R Mercieca-Bebber, H Rice, L Gabb, M King Quality of Life Research 25, 559-574, 2016 | 129 | 2016 |
| Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review R Mercieca-Bebber, MJ Palmer, M Brundage, M Calvert, MR Stockler, ... BMJ open 6 (6), e010938, 2016 | 127 | 2016 |
| Patient, client, consumer, survivor or other alternatives? A scoping review of preferred terms for labelling individuals who access healthcare across settings DSJ Costa, R Mercieca-Bebber, S Tesson, Z Seidler, AL Lopez BMJ open 9 (3), e025166, 2019 | 106 | 2019 |
| Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30 MT King, R Viney, A Simon Pickard, D Rowen, NK Aaronson, JE Brazier, ... Pharmacoeconomics 36, 225-238, 2018 | 93 | 2018 |
| Systematic evaluation of patient-reported outcome protocol content and reporting in cancer trials D Kyte, A Retzer, K Ahmed, T Keeley, J Armes, JM Brown, L Calman, ... JNCI: Journal of the National Cancer Institute 111 (11), 1170-1178, 2019 | 90 | 2019 |
| SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials M Calvert, M King, R Mercieca-Bebber, O Aiyegbusi, D Kyte, A Slade, ... BMJ open 11 (6), e045105, 2021 | 89 | 2021 |
| Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols D Kyte, H Duffy, B Fletcher, A Gheorghe, R Mercieca-Bebber, M King, ... PloS one 9 (10), e110229, 2014 | 88 | 2014 |
| Patient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writers M Calvert, D Kyte, H Duffy, A Gheorghe, R Mercieca-Bebber, J Ives, ... PloS one 9 (10), e110216, 2014 | 88 | 2014 |
| The impact of cancer on psychological and social outcomes DSJ Costa, R Mercieca‐Bebber, C Rutherford, L Gabb, MT King Australian Psychologist 51 (2), 89-99, 2016 | 79 | 2016 |
| How is quality of life defined and assessed in published research? DSJ Costa, R Mercieca-Bebber, C Rutherford, MA Tait, MT King Quality of Life Research 30, 2109-2121, 2021 | 73 | 2021 |
| Preliminary evidence on the uptake, use and benefits of the CONSORT-PRO extension R Mercieca-Bebber, J Rouette, M Calvert, MT King, L McLeod, P Holch, ... Quality of Life Research 26, 1427-1437, 2017 | 53 | 2017 |
| The EORTC Quality of Life Questionnaire for cancer patients (QLQ‐C30): Australian general population reference values R Mercieca‐Bebber, DSJ Costa, R Norman, M Janda, DP Smith, ... Medical Journal of Australia 210 (11), 499-506, 2019 | 51 | 2019 |
| The patient-reported outcome content of international ovarian cancer randomised controlled trial protocols R Mercieca-Bebber, M Friedlander, PS Kok, M Calvert, D Kyte, M Stockler, ... Quality of Life Research 25, 2457-2465, 2016 | 44 | 2016 |
| Patient-reported outcomes in head and neck and thyroid cancer randomised controlled trials: A systematic review of completeness of reporting and impact on interpretation RL Mercieca-Bebber, A Perreca, M King, A Macann, K Whale, S Soldati, ... European Journal of Cancer 56, 144-161, 2016 | 43 | 2016 |
| The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and training R Mercieca-Bebber, M Calvert, D Kyte, M Stockler, MT King Contemporary clinical trials communications 9, 23-32, 2018 | 38 | 2018 |
| Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic … MT King, MR Stockler, P Butow, R O’Connell, M Voysey, AM Oza, K Gillies, ... International Journal of Gynecologic Cancer 24 (5), 2014 | 37 | 2014 |
| UK utility weights for the EORTC QLU‐C10D R Norman, R Mercieca‐Bebber, D Rowen, JE Brazier, D Cella, ... Health economics 28 (12), 1385-1401, 2019 | 35 | 2019 |
